A carregar...
Blood-Brain Barrier and Delivery of Protein and Gene Therapeutics to Brain
Alzheimer’s disease (AD) and treatment of the brain in aging require the development of new biologic drugs, such as recombinant proteins or gene therapies. Biologics are large molecule therapeutics that do not cross the blood-brain barrier (BBB). BBB drug delivery is the limiting factor in the futur...
Na minha lista:
| Publicado no: | Front Aging Neurosci |
|---|---|
| Autor principal: | |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Frontiers Media S.A.
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6966240/ https://ncbi.nlm.nih.gov/pubmed/31998120 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3389/fnagi.2019.00373 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|